Middle East respiratory syndrome vaccines | Zendy

Stanley Perlman | Zendy; Rahul Vijay | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Middle East respiratory syndrome vaccines

Author(s) -

Stanley Perlman,

Rahul Vijay

Publication year - 2016

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2016.04.008

Subject(s) - middle east respiratory syndrome coronavirus , middle east respiratory syndrome , vaccination , medicine , virology , transmission (telecommunications) , covid-19 , coronavirus infections , respiratory system , immunology , disease , infectious disease (medical specialty) , pathology , computer science , telecommunications

The Middle East respiratory syndrome coronavirus (MERS-CoV) has infected over 1600 individuals with nearly 600 deaths since it was first identified in human populations in 2012. No antiviral therapies or vaccines are available for its treatment or prophylaxis. Approaches to the development of MERS vaccines are discussed herein, including a summary of previous efforts to develop vaccines useful against human and non-human coronaviruses. A striking feature of MERS is the important role that camels have in transmission. Camel vaccination may be a novel approach to preventing human infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research